Ann: Photosoft shows activity against Dengue in Preliminary Assay, page-9

First 9 Last

Share
Profile

Follow
Troisi

592 Posts.

65

26/10/22

20:21

Post #: 64416241
Share

Originally posted by WombatKeith: ↑

My options expire in June 2023. I averaged down recently so I am "only" 64% in the red.

As GregWallis says, when all the work is done they will rerate. I expect that there will be opportunities to re-rate as the process progresses and the percieved risks are resolved.

By their releases, the system is proven non toxic and proven to work both as a therapy for killing tumours and an adjunct therapy to assist in surgical excision of tumours.

It works on viral infections that are extremely problematic with existing treatments (did I see ebola in a recent release?). It is hard to see any reason why this technology could fail so IMHO, it will not fail.

If I have a big win elsewhere, I might average down further and grab another 10 million at point 1 of a cent.

The range and scope and efficacy of these treatments are so massive that, in my wildest dreams, this could be another CSL. That would put me in billionaire teritory and the top 20 of the rich list (along with many other option holders I'm guessing). Clearly, this is getting "a little" ahead of things. I have no rational means of calculating how valuable this mob will be once the technology is approved, but it will be big in my opinion.

One for the bottom drawer for now.

GLTAH

Expand

Wombat, i agree with you but whilst interest rates are going up small caps will continue getting smashed. Not much we can do about that. But you have to be in it to win it

IVX Price at posting: 1.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HAR

Haranga jumps +7% on Lincoln acquisition

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.0¢		Change 0.004(4.17%)		Mkt cap ! $8.541M

Open	High	Low	Value	Volume
9.7¢	10.0¢	9.6¢	$6.613K	66.75K

Buyers (Bids)

No.	Vol.	Price($)
1	75887	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	294638	3

View Market Depth

No.	Vol.	Price($)
1	75887	0.096
2	60000	0.095
1	47000	0.094
1	25000	0.093
1	42667	0.092

Price($)	Vol.	No.
0.100	294638	3
0.105	22162	2
0.110	28153	1
0.115	58455	2
0.120	20233	2

Last trade - 15.14pm 30/07/2025 (20 minute delay)

IVX (ASX) Chart

Ann: Photosoft shows activity against Dengue in Preliminary Assay, page-9

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Haranga jumps +7% on Lincoln acquisition

Ionic Rare Earths falls -7% as momentum slips on vague production update

Neurizon inks $1.5M loan against R&D Tax Rebate

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Photosoft shows activity against Dengue in Preliminary Assay, page-9

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Haranga jumps +7% on Lincoln acquisition

Ionic Rare Earths falls -7% as momentum slips on vague production update

Neurizon inks $1.5M loan against R&D Tax Rebate

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News